1. Home
  2. CRT vs DRIO Comparison

CRT vs DRIO Comparison

Compare CRT & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cross Timbers Royalty Trust

CRT

Cross Timbers Royalty Trust

HOLD

Current Price

$11.31

Market Cap

63.9M

Sector

Energy

ML Signal

HOLD

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$6.82

Market Cap

52.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRT
DRIO
Founded
1991
2011
Country
United States
United States
Employees
2
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.9M
52.8M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CRT
DRIO
Price
$11.31
$6.82
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
19.1K
19.5K
Earning Date
04-14-2026
05-14-2026
Dividend Yield
5.29%
N/A
EPS Growth
N/A
1559.02
EPS
N/A
1.75
Revenue
N/A
$7,394,000.00
Revenue This Year
N/A
$20.27
Revenue Next Year
N/A
$47.58
P/E Ratio
$11.55
$4.02
Revenue Growth
N/A
43.02
52 Week Low
$7.07
$5.84
52 Week High
$11.43
$17.74

Technical Indicators

Market Signals
Indicator
CRT
DRIO
Relative Strength Index (RSI) 75.76 45.97
Support Level $10.18 $6.18
Resistance Level N/A $8.10
Average True Range (ATR) 0.27 0.60
MACD 0.06 -0.02
Stochastic Oscillator 85.00 29.19

Price Performance

Historical Comparison
CRT
DRIO

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: